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rate in office-based three-port microincision
vitrectomy surgery using Retrector technology
Flavio A Rezende1,2,4*†, Cynthia X Qian1,3† and Przemyslaw Sapieha1Abstract
Background: To perform a microbiological contamination analysis of the vitreous during office-based micro-incision
vitrectomy surgery (MIVS) assessing whether the bacteria detected correlated with patient's ocular conjunctival flora.
Methods: This is a prospective, interventional, nonrandomized case series of patients undergoing office-based MIVS,
anti-VEGF, and dexamethasone intravitreal injections (triple therapy) for the treatment of wet age-related macular
degeneration (AMD) and diabetic macular edema (DME).
All patients were operated at a small procedure room in an ambulatory clinic of the Department of
Ophthalmology, University of Montreal, Quebec, Canada. Conjunctival samples were done before placing the
sclerotomies. The MIVS was done with a 23-gauge retractable vitrector, a 27-gauge infusion line, and a 29-gauge
chandelier. Undiluted and diluted vitreous were collected for aerobic, anaerobic and fungal cultures. Outcomes
measured were bacterial species identification within samples collected from the conjunctiva and the vitreous.
Results: Thirty-seven patients (37 eyes) were recruited and completed over 17 months of follow-up. Twenty-eight had
wet AMD and nine had DME. There were 13 men and 24 women, with a mean age of 78 years. Eighteen patients
(46%) had culture positive conjunctival flora. Twenty-six bacterial colonies were tabulated in total from the conjunctival
swabs. All bacteria detected were gram-positive bacteria (100%), most commonly: Staphylococcus epidermitis in 11
(42%) and Corynebacterium sp. in 6 (23%). Only 1/18 patients had more than 3 species isolated, 6/18 patients had 2
species and 11/18 patients had 1 species identified on the conjunctival swab. Only 1 of the 37 undiluted midvitreous
samples was culture positive, equating to a contamination rate of 2.7%. None of the diluted vitreous samples were
culture positive. All cultures were negative for fungus. No serious postoperative complications occurred, including
bacterial endophthalmitis, choroidal detachment, and retinal detachment.
Conclusion: This preliminary study of office-based MIVS gives us insights on the ocular surface microbial profile
and vitreous contamination rate of performing such procedures outside the OR-controlled environment. Our initial
results seem to indicate that there is little risk of bacterial translocation and contamination from the conjunctiva into
the vitreous. Therefore, if endophthalmitis occurs post-operatively, the source may likely arise after the procedure.
Larger studies are needed to confirm our data.* Correspondence: frezendef@hotmail.com
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Figure 1 Office-based vitrectomy set-up. All procedures were
performed in an in-clinic non-sterile non-positive pressure procedure
room. Note that the surgeon is gloved and masked but not gowned.
The instruments were handled in a sterile manner.
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The recent technological innovations in continually re-
fining and decreasing gauge size for vitreoretinal surger-
ies have further ignited interest in the development of
office-based, portable microincision vitrectomy surgery
(MIVS). Indeed, the concept of bringing vitrectomy sur-
gery out of the operating room (OR) is not new. Starting
in the early 1980s, case series on the successful use of
portable vitrectors in rural, non-OR settings have been
reported [1,2]. One of the latest commercial models is a
cannula-less 23-ga needle with an incorporated 25-ga
vitrector called the Retrector whose indications have
evolved from a simple tap and inject to numerous diag-
nostic and therapeutic functions [3-5].
With the introduction of a new surgical technique, in-
creased risks of complications and endophthalmitis are
always a major concern [6,7]. One of the main suspected
routes of contamination is through the transconjunctival
pathway, in which insertion of surgical instruments dir-
ectly through conjunctiva may inadvertently track ocular
surface organisms into the vitreous [6-9].
In this prospective study, we sought to assess the rate
of conjunctival bacterial translocation and vitreous con-
tamination following office-based three-port vitrecto-
mies performed using the Retrector portable vitrector.
We also evaluated whether the vitreous isolates corre-
lated to the species identified from the same patients’
conjunctiva.
Methods
Surgical method and sample collection
All patients were followed by a single retina specialist
(FAR) and had been previously diagnosed with exudative
age-related macular degeneration (AMD) or diabetic macu-
lar edema (DME). They were recruited from a pilot study
on vitreous lipidomics measurements and quantification of
intravitreal levels of different cytokines (Study ID: HMR-
10059, www.clinicaltrials.gov), depending on the presence or
absence of daily oral omega-3 supplementation received
[Rezende, FA, Lapalme, E, Qian, CX, et al. Omega-3 supple-
mentation influences vitreal levels of Vascular Endothelial
Growth Factor in Exudative Age-Related Macular Degener-
ation. Paper presented at: ARVO Annual Meeting, May 8
2012, Ft Lauderdale]. Those who had received a minimum
of 2 months of omega-3 supplementation prior to interven-
tion were compared to case-matched patients who had re-
ceived no supplements. For cytokines levels and lipidomics
profiling, all patients underwent a one-time vitreous biopsy
where undiluted vitreous samples were collected at the time
of anti-VEGF (bevacizumab 1.25 mg/0.05 ml) and dexa-
methasone injections using a portable office-based vitrec-
tomy device (Retrector, Insight Instruments, Inc, Stuart, FL)
[4,10-12]. Half of each vitreous sample was sent for cyto-
kines and lipidomics analysis whereas the other half wassent along with conjunctival samples for microbial analysis.
Patients were excluded if they had evidence of local or
systemic infections. The entire procedure was per-
formed as an outpatient procedure in the minor pro-
cedure room of the ophthalmology ambulatory center
at Maisonneuve-Rosemont Hospital. One single sur-
geon performed all surgeries using a mask and sterile
gloves, as would be performed for a routine anti-VEGF
injection (Figure 1). All instruments were opened and
handled in a sterile manner. The study conforms to the te-
nets of the declaration Helsinki and was approved by the
Institutional Review Board of the Maisonneuve-Rosemont
Hospital affiliated with the University of Montreal.
Initial conjunctival sampling
After written informed consent was obtained, the first
conjunctival specimen sampling was performed prior to
any anaesthetic or topical drops. Calcium alginate swabs
were passed several times over the bulbar conjunctiva
and then plated unto anaerobic and aerobic sleep blood
agar, chocolate agar, Sabouraud agar and an enriched
brain-heart infusion broth. The fornix was not sampled.
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with the lashes or conjunctival areas other than those
that would lie directly over where the 3 ports were placed.
The patients then received topical anaesthetic drops
followed by a peribulbar injection of 2% lidocaine without
epinephrine.Vitrectomy
All procedures were performed in an in-clinic non-sterile
non-positive pressure procedure room. 5% povidone-
iodine was used to clean the periocular skin and topical
instillation into the eye and within the cul-de-sac was left
in place for 5 minutes. The surgeon was gloved and
masked but not gowned. The instruments were handled
in a sterile manner. Patients were then draped in a stand-
ard sterile manner with placement of a lid speculum. A
27-ga self-retaining line (Insight Instruments, Stuart, FL)
for balanced salt solution (BSS) infusion was first placed,
followed by a 29-ga chandelier placement connected to a
mercury vapor light source (Synergetics, O’Fallon, Mo).
The surgical view during the procedure was provided
through a surgical operative microscope and a Volk con-
tact lens (Volk direct image 1.5x magnifying disposable vi-
trectomy lens, OH, USA). The vitrectomy was performed
using a 25-ga sutureless Retrector system (Insight Instru-
ments, Stuart, FL) in all patients. The model used in the
study is a portable, battery-powered system with a max-
imum cut rate of 600 cpm and features a single-use re-
tractable sheathed guillotine cutter (25-ga) within an in-built
needle (23-ga). The needle was introduced bevel down
through displaced conjunctiva in an oblique one-plane tun-
nel into the vitreous cavity 3-4 mm from the limbus
(Figure 2) [3-5]. With the exception of the portable vitrector
motor handpiece, which was placed within a sterile plasticFigure 2 Set-up for office-based 3-port MIVS; superotemporally,
inserted Retrector, inferotemporally self-retaining 27-ga infusion
line and superonasally, 29-ga self-retaining chandelier illumination
system.cover when in use, all other instruments used were sterile
and disposable.
Two other specimens were obtained from the vitreous
cavity at the beginning and the end of vitrectomy. The
first undiluted sample was aspirated using a sterile 1.0 ml
syringe connected to the aspiration line of the portable
vitrector. A minimum of 0.5 ml of undiluted vitreous fluid
was cut and removed from the mid-vitreous through con-
trolled manual aspiration, all the while visually monitoring
for and avoiding globe collapse.
At the end of the vitrectomy, a second 10 ml sample
of vitreous diluted through continuous BSS infusion was
again manually collected in through the vitrector aspir-
ation line. Both vitreous samples were promptly capped
after collection and sent to the microbiology department
at the end of the case. 0.8 mg (0.2 ml) of preservative-
free dexamethasone and 2.5 mg (0.1 ml) of bevacizumab
were then delivered on separate 30-ga needles into the
eye through the 29-ga trocar after chandelier removal.
The intraocular pressure (IOP) was digitally assessed
and, if necessary, the remaining volume deficit was com-
pensated by BSS. The integrity of the sutureless wounds
was verified. If a leak or vitreous wick was noted, vitre-
ous was removed with the vitrector and thermocauter-
ization was applied to coapt the conjunctiva overlying
the sclerotomy site. None of the sclerotomies needed to
be sutured. All patients were seen at 24 hours, 1 week
and 1 month postoperatively for follow-up.
Bacterial cultures
Conjunctival samples and both undiluted and dilute vit-
reous samples were directly transported after collection
to the Department of Microbiology of the same institu-
tion for further analysis with a delay <1 h after collec-
tion. The unplated vitreous samples were cultured under
aseptic techniques unto anaerobic and aerobic agars. In-
cubation was performed at 37°C for 48 hours aerobically
in an atmosphere of 7% CO2 and then anaerobically.
Sabouraud agar at 25°C was used to enhance fungal iso-
lation. Bacterial samples were kept for at least 1 week
while fungal cultures were held for 1 month. Quantita-
tive data were expressed as mean ± SD. Associations be-
tween microbial data and clinical findings that may
predispose to bacterial presence was expressed as an
odds-ratio. (SPSS for Mac; SPSS, Inc, Chicago, IL). Stat-
istical significance was defined as P < .05.
Results
A total of 37 consecutive eyes (37 patients) were re-
cruited to the study between June 2011 and end of 2012.
There were 13 men and 24 women. The mean age of pa-
tients was 77.9 ± 7.4 years and the mean follow-up time
since vitrectomy was 16.9 ± 2.0 months. Five patients
were on daily glaucoma medication drops, which were
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tients wore contact lenses or used topical antibiotics in
the 4 weeks prior to sampling. All patients continued to
receive regular anti-VEGF treatments if their AMD or
DME were deemed active after the office-based MIVS
(Table 1).
In all, 18 patients (46%) had culture positive conjunc-
tival flora for a total of 26 colonies from eight different
species of bacteria. All of these isolates (100%) were
gram-positive and identified as organisms found as part
of the normal ocular flora [13]. The most commonly
found species were Staphylococcus epidermitis (11/26;
42%) and Corynebacterium sp (6/26; 23%). Only 1/18 pa-
tients had ≥3 species isolated (Staphylococcus epidermi-
tis, Staphylococcus warneri, Streptococcus mitis), 6/18Table 1 Patient characteristics
Parameters N %
No eyes/patients 37
- Left eyes 12 32%
- Right eyes 25 68%
No. Men/women
- Men 13 35%
- Women 24 65%
Age
- Mean ± SD 77.9 ± 7.4 years
- Range 46-97 years
Follow-up
- Mean ± SD 16.8 ± 2.0 months
- Range 6-19 months
Diagnosis
- Exudative AMD 28 76%
- DME 9 24%
Phakic status
- Phakic 16 43%
- Pseudophakic 21 57%
- Aphakic 0 0%
Medical conditions*
- Glaucoma 5 14%
- Hypertension 17 46%
- Diabetes 14 38%
- Hyperlipidemia 8 22%
- Hypothyroidism 5 14%
- CAD 4 11%
- Asthma 4 11%
- Osteoporosis 2 5%
CAD: coronary artery disease; SD: standard deviation; DME: diabetic
macular edema.
*Medical conditions are non-additive and one patient may manifest several of
the most common comorbid conditions.patients had 2 species and 11/18 patients had 1 species
identified on the conjunctival swab (Table 2).
Only 1 of the 37 undiluted midvitreous samples was
culture positive, equating to a contamination rate of
2.7%. The bacterium isolated was Propionibacterium sp.
This patient’s conjunctiva also grew Propionibacterium
sp. The dilute vitreous sample from this patient was cul-
ture negative. None of the 37 dilute midvitreous samples
were culture positive and there was no fungal growth in
any sample.
Although there was a slightly higher rate of male gender
(OR 1.01, 95% CI 0.26-3.92, P = 0.99), diabetes mellitus
(OR 1.30, 95% CI 0.34-4.93, P = 0.39) and hypertension
(OR 1.92, 95% CI 0.52-7.00, P = 0.32) amongst those with
detection of positive conjunctival flora cultures, the values
were not statistically significant.
All patients did well after samples collection. Only one
patient in the cohort experienced asymptomatic hypot-
ony with an intraocular pressure of 6 on post-operative
day 1. This transient phenomenon self-resolved com-
pletely on the next follow-up one week later. None de-
veloped serious postoperative complications, including
bacterial endophthalmitis, choroidal detachment, and
retinal detachment.
Discussion
The use of modern office-based vitrectomy has greatly
evolved since it was first introduced [3-5,10-12,14]. Newer
models have allowed for better visualization and more pre-
cise surgical maneuvers to be performed within the clinic
or minor procedure room. While not a replacement for in-
OR 3-port pars-plana vitrectomy, the potential of the
office-based vitrector now seems expansive [3,4,10-12,14].
The incidence of reported complications and endophthal-
mitis following office-based vitrectomy remains largely
unknown. The largest combined study to date of 4509
single-port procedures performed using the Intrector
places endophthalmitis rates at around 0.17% (62.9% in
an office setting, 37.1% in an OR setting) [5]. This data
differs from our study’s surgical model where allTable 2 Most commonly isolated bacterial species from
conjunctival surface
Bacterium Conjunctival flora N (%)
Staphylococcus epidermitis 11 (42%)
Corynebacterium sp. 6 (23%)
Propionibacterium sp. 3 (12%)
Staphylococcus auricularis 2 (8%)
Staphylococcus aureus 1 (4%)
Corynebacterium macginleyi 1 (4%)
Staphylococcus warneri 1 (4%)
Streptococcus mitis 1 (4%)
sp: species.
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setting. Comparatively, modern endophthalmitis rates for
standard 23-ga and 25-ga MIVS are reported at around
0.02-0.10%, although values ranging from 0.02%-0.80%
have been described throughout the years [9,15-23].
Our study is the first to detail microbial colonization
of the ocular surface and corresponding vitreous con-
tamination for office-based portable MIVS. Our prelim-
inary survey suggests that this is a well-tolerated procedure
with little long-term complications. Our conjunctival flora
culture positivity is slightly lower than that previously re-
ported in vitrectomy literature (46% instead of 61-98%) [8].
This may be due to the difference in our sampling method.
To reduce lid contamination, we only cultured the bulbar
conjunctiva where the instruments would be introduced.
Based on prior literature, we also chose not to administer
prophylactic topical antibiotics to patients prior to sampling
[6,8]. Despite the lack of topical antibacterial prophylaxis,
only 1/68 vitreous samples were culture positive. It is likely
that the 5% povidone-iodine preparation left on the surgical
field for 5 minutes prior to the start of the case is in part re-
sponsible for this finding [6,7,9]. Shimada et al. have even
advocated for the repeated irrigation of 0.25% povidone-
iodine unto the surgical field during a procedure to reduce
vitreous contamination. However, as per the authors, the
safety and efficacy of such a practice needs further statis-
tical confirmation from a larger scale study necessitating
enrollment of over 50,000 eyes [7].
Several studies postulated that compared to the 20-ga
vitrector, the smaller lumen of a 25-ga instrument re-
duces the infusion rate of BSS, hence slowing the “flush-
ing” of the vitreous cavity, making the exit of bacteriaFigure 3 Vitreous wick. Trypan blue staining of the conjunctiva highlight
the vitreous was cut and removed with the vitrector and conjunctiva was cmore difficult [8,16,17,23]. In the case series presented
by Tominaga et al. on the microbiological study compar-
ing 20-ga to 25-ga vitrectomies, 22.5% (9/40) of patients
undergoing 25-ga MIVS had vitreous contamination at
the beginning of the vitrectomy surgery. This number
decreased to 0% at the end of the vitrectomy, with the
authors hypothesizing that the constant infusion of BSS
during surgery might possibly play a “cleansing” role
[8,16,23]. Our own results did not demonstrate such a
dramatic decrease in vitreous bacterial load since there
was already little bacterial contamination at the begin-
ning of vitrectomy. Perhaps this may be due to the re-
duced surgical time (on average 10 minutes) and the
sturdy hypodermic, needle-type build of the Retrector,
manufacturing sharper and cleaner wounds [5].
A positive vitreous culture fortunately does not often
lead to endophthalmitis. Previous studies in both cata-
ract and vitrectomy literature have shown that in most
surgical cases with culture-proven anterior chamber or
vitreous contamination, there is no spread of infection.
For example, Egger et al. studied 25 consecutive subjects
undergoing primary 20-ga pars plana vitrectomy: 32%
(n = 8) had vitreous contamination at the beginning of
vitrectomy surgery, 20% (n = 5) had vitreous contamin-
ation towards the end of surgery, yet none developed
endophthalmitis postoperatively [19]. More recently in
cataract literature, several studies have shown that the
approximate rate of anterior chamber contamination
at the end of uncomplicated surgery is around 2%, yet
the rate of acute postoperative endophthalmitis is below
0.1% [24-26]. Conversely, a negative culture does not
equate to a sterile environment and endophthalmitis maying a vitreous wick after removal of the 23-gauge Retrector. If present,
losed with cauterization.
Rezende et al. BMC Ophthalmology 2014, 14:58 Page 6 of 7
http://www.biomedcentral.com/1471-2415/14/58still arise. This may be due to two main reasons. First, only
a portion of the vitreous is sampled and bacteria present
in low numbers may have been missed during collection
or that the culture method was not sensitive enough to
detect the minute amount of organisms. Second, if the
contamination does not arise from the conjunctiva pre-
and intra-operatively, it may still occur post-operatively.
On several occasions, we observed and documented on
high magnification with Trypan blue staining the active
prolapse of vitreous content through the sclerotomy after
removal of the vitrector needle (Figure 3). If this prolapse
remains incarcerated, this would imply the establishment
of a patent conduit between the ocular cavity and the ex-
ternal surface in the post-operative period. This led us to
pay particular attention to better conjunctival wound clos-
ure at the end of each case [9,15-17,22,23].
While the conclusions of our study are thought pro-
voking, some inherent limitations to experimental design
include the single surgeon, prospective nature of the
current study, limiting extrapolations as to the external
validity of this study. In addition, the patient cohort is
small, with a relatively low bacterial detection rate within
both undiluted and diluted vitreous. It is possible that to
increase the sensitivity of bacterial detection and to fur-
ther prove that the same genetic strain of bacteria within
the vitreous cavity came from the conjunctival flora, quan-
titative PCR could be used in addition to conventional cul-
ture in future cases [27-30]. Currently, such techniques
have only been advocated for cases when minute quan-
tities of bacteria are present, especially once antibacterial
or antiviral therapies have been initiated [24,28-31].
Conclusion
The observed microbiological profiles indicate that al-
though the ocular surface is well inhabited by gram-
positive flora, the risks of vitreous bacterial contamination
is low during the set-up and process of the surgery. Hence,
the usefulness of BSS infusion in vitreous cleansing re-
mains to be further elucidated. We hope that increased
experience and attention paid in future large-scale studies
to the possible routes of post-operative contamination will
streamline approaches and further mitigate the current
rates of endophthalmitis in office-based vitrectomies. We
hope to witness this evolution make its use easier and
more accessible in the future as a safe alternative to con-
ventional vitrectomy for simple and short vitreoretinal
surgical cases.
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